Advertisement

ADVERTISEMENT

outcomes research

Research in Review
Aggressive Care Associated With Poorer Outcomes for Patients With NSCLC at End of Life
06/14/2017
JCP Editors
Aggressive care in the last month of life for patients with non–small cell lung cancer (NSCLC) is associated with lower family evaluations of end-of-life care. Patients with advanced NSCLC who are nearing...
Aggressive care in the last month of life for patients with non–small cell lung cancer (NSCLC) is associated with lower family evaluations of end-of-life care. Patients with advanced NSCLC who are nearing...
...
06/14/2017
Journal of Clinical Pathways
Research in Review
Biologic Therapy Not Cost-Effective in Patients With RA
06/13/2017
JCP Editors
A cost-effectiveness analysis showed that patients with rheumatoid arthritis (RA) who switch from a disease-modifying antirheumatic drug (DMARD) to a biologic drug are likely to increase costs of care while receiving...
A cost-effectiveness analysis showed that patients with rheumatoid arthritis (RA) who switch from a disease-modifying antirheumatic drug (DMARD) to a biologic drug are likely to increase costs of care while receiving...
A...
06/13/2017
Journal of Clinical Pathways
Research in Review
High Response Rates With New Treatment for Aggressive B-Cell Lymphoma
06/13/2017
JCP Editors
In a recent trial, researchers determined complete response rates in patients with aggressive B-cell lymphomas after treatment with new a CAR T-cell product. ----- Related Content B-Cell ALL Disease Burden May...
In a recent trial, researchers determined complete response rates in patients with aggressive B-cell lymphomas after treatment with new a CAR T-cell product. ----- Related Content B-Cell ALL Disease Burden May...
In a...
06/13/2017
Journal of Clinical Pathways
Research in Review
Immunotherapy Improves Standard of Care for Multiple Myeloma
06/08/2017
JCP Editors
Adding a targeting agent to standard of care carfilzomib, lenalidomide, and dexamethasone (KRd) for multiple myeloma is a safe and efficacious alternative to autologous stem cell transplantation (ASCT) with KRd,...
Adding a targeting agent to standard of care carfilzomib, lenalidomide, and dexamethasone (KRd) for multiple myeloma is a safe and efficacious alternative to autologous stem cell transplantation (ASCT) with KRd,...
Adding...
06/08/2017
Journal of Clinical Pathways
Research in Review
Early PET Scan Improves Outcomes for Patients With Hodgkin Lymphoma
06/08/2017
JCP Editors
Response to positron emission tomography (PET) scan after two cycles of standard treatment allows for early treatment adaption for patients with early-stage Hodgkin lymphoma, according to research published in the...
Response to positron emission tomography (PET) scan after two cycles of standard treatment allows for early treatment adaption for patients with early-stage Hodgkin lymphoma, according to research published in the...
...
06/08/2017
Journal of Clinical Pathways
Research in Review
Prolonged PFS, QoL in Ovarian Cancer After Maintenance Therapy
06/08/2017
JCP Editors
Women with BRCA-mutated relapsed serous ovarian cancer who received maintenance therapy after platinum-based chemotherapy prolonged their progression-free survival (PFS) by almost 7 months, according to results of a...
Women with BRCA-mutated relapsed serous ovarian cancer who received maintenance therapy after platinum-based chemotherapy prolonged their progression-free survival (PFS) by almost 7 months, according to results of a...
Women...
06/08/2017
Journal of Clinical Pathways
Research in Review
Combination Therapy Improves Outcomes for Patients With MCL
06/08/2017
JCP Editors
Patients with mantle cell lymphoma (MCL) have increased odds of achieving complete remission after being treated with a combination regimen, according to research presented at the 2017 ASCO Annual Meeting (June 2-6,...
Patients with mantle cell lymphoma (MCL) have increased odds of achieving complete remission after being treated with a combination regimen, according to research presented at the 2017 ASCO Annual Meeting (June 2-6,...
...
06/08/2017
Journal of Clinical Pathways
Research in Review
CAR T-Cells May Have Therapeutic Value in Solid Cancers
06/07/2017
JCP Editors
Chimeric antigen receptor (CAR) T-cells may elicit responses in solid cancers by inducing cancer cell death and the release of tumor antigens that could stimulate T-cell activity, according to research presented at...
Chimeric antigen receptor (CAR) T-cells may elicit responses in solid cancers by inducing cancer cell death and the release of tumor antigens that could stimulate T-cell activity, according to research presented at...
...
06/07/2017
Journal of Clinical Pathways
Research in Review
Metastatic Hormone-Naïve Prostate Cancer Effectively Treated With Combination Therapy
06/07/2017
JCP Editors
Groundbreaking results of a trial have shown that the combination of a new drug with androgen deprivation therapy (ADT) significantly improves overall survival (OS) and radiographic progression-free survival (PFS) in...
Groundbreaking results of a trial have shown that the combination of a new drug with androgen deprivation therapy (ADT) significantly improves overall survival (OS) and radiographic progression-free survival (PFS) in...
...
06/07/2017
Journal of Clinical Pathways
Gemcitabine-Based Chemoradiation Effective Bladder Cancer Treatment for Underdeveloped Nations
06/04/2017
JCP Editors
Neoadjuvant gemcitabine-based chemotherapy, followed by gemcitabine-based concomitant chemoradiation, may aid in bladder preservation for patients receiving treatment for muscle-invasive bladder cancer in...
Neoadjuvant gemcitabine-based chemotherapy, followed by gemcitabine-based concomitant chemoradiation, may aid in bladder preservation for patients receiving treatment for muscle-invasive bladder cancer in...
...
06/04/2017
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
AIBD logo
December 9 ⁠–⁠ December 11
December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
December 14 ⁠–⁠ December 15
February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use